Alexandre Luz de Castro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexandre Luz de Castro has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Alex Sander da Rosa Araujo
Department of Physiology, Basic Sciences Institute of Health, Federal University of Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil
13 shared publications - Adriane Belló-Klein
Laboratory of Cardiovascular Physiology and Reactive Oxygen Species, Physiology Department, Institute of Basic Health Science (ICBS), Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos Street, 2600-Santa Cecília, Porto Alegre 90035-003, Rio Grande do Sul, Brazil
12 shared publications - Patrick Türck
Department of Physiology, Basic Sciences Institute of Health, Federal University of Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil
9 shared publications Adriane Belló-Klein
Laboratory of Cardiovascular Physiology and Reactive Oxygen Species, Physiology Department, Institute of Basic Health Science (ICBS), Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos Street, 2600, Santa Cecília, CEP: 90035-003, Porto Alegre, RS, Brazil
6 shared publications- Fernanda Visioli
Universidade Federal do Rio Grande do Sul
6 shared publications Tânia Regina G. Fernandes
Laboratory of Cardiovascular Physiology and Reactive Oxygen Species, Physiology Department, Institute of Basic Health Science (ICBS), Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos Street, 2600, Santa Cecília, CEP: 90035-003, Porto Alegre, RS, Brazil
6 shared publications
Latest Publications
- Open Access
- 29 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1939
Red Araça (Psidium cattleianum) Extract Prevents Right Ventricular Hypertrophy in Experimental Pulmonary Arterial Hypertension
Background: Pulmonary artery hypertension (PAH) is characterised by progressive pulmonary vascular remodelling and increased pulmonary vascular resistance, leading to right ventricular (RV) dysfunction and failure. Red araça (Psidium cattleianum) extract is derived from native Brazilian fruit rich in phenolic compounds with recognised antioxidant and anti-inflammatory properties. Objectives: The present study aimed to evaluate the preventive effects of red araça extract administration on RV remodelling and pulmonary arteriole alterations in rats with MCT-induced PAH. Methods: Male Wistar rats were divided into three groups: control, monocrotaline (MCT), and MCT + red araça extract. PAH was induced by a single intraperitoneal injection of MCT (60 mg/kg), and the treated group received red araça extract (5 mL/kg/day) by gavage for 21 days. Echocardiographic, hemodynamic, morphometric, molecular, and histological analyses were subsequently performed. Results: The MCT group exhibited increased pulmonary vascular resistance and RV hypertrophy, impaired RV function, elevated TLR4 and xanthine oxidative (XO) protein expression, elevated Akt activation, and marked increase in pulmonary arteriole wall thickness. Treatment with red araça extract prevented RV hypertrophy, reduced total pulmonary vascular resistance, preserved Akt activation similar to control, and decreased TLR4 and XO protein expression in the RV. In addition, administration of red araça extract prevented the increase in pulmonary arteriolar wall thickness. Conclusions: Collectively, these findings suggest that red araça extract attenuates cardiopulmonary alterations associated with experimental PAH, possibly involving modulation of the expression of proteins related to cardiac hypertrophy and inflammation.
- 29 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1939
Open AccessRed Araça (Psidium cattleianum) Extract Prevents Right Ventricular Hypertrophy in Experimental Pulmonary Arterial Hypertension
Background: Pulmonary artery hypertension (PAH) is characterised by progressive pulmonary vascular remodelling and increased pulmonary vascular resistance, leading to right ventricular (RV) dysfunction and failure. Red araça (Psidium cattleianum) extract is derived from native Brazilian fruit rich in phenolic compounds with recognised antioxidant and anti-inflammatory properties. Objectives: The present study aimed to evaluate the preventive effects of red araça extract administration on RV remodelling and pulmonary arteriole alterations in rats with MCT-induced PAH. Methods: Male Wistar rats were divided into three groups: control, monocrotaline (MCT), and MCT + red araça extract. PAH was induced by a single intraperitoneal injection of MCT (60 mg/kg), and the treated group received red araça extract (5 mL/kg/day) by gavage for 21 days. Echocardiographic, hemodynamic, morphometric, molecular, and histological analyses were subsequently performed. Results: The MCT group exhibited increased pulmonary vascular resistance and RV hypertrophy, impaired RV function, elevated TLR4 and xanthine oxidative (XO) protein expression, elevated Akt activation, and marked increase in pulmonary arteriole wall thickness. Treatment with red araça extract prevented RV hypertrophy, reduced total pulmonary vascular resistance, preserved Akt activation similar to control, and decreased TLR4 and XO protein expression in the RV. In addition, administration of red araça extract prevented the increase in pulmonary arteriolar wall thickness. Conclusions: Collectively, these findings suggest that red araça extract attenuates cardiopulmonary alterations associated with experimental PAH, possibly involving modulation of the expression of proteins related to cardiac hypertrophy and inflammation.
- 29 October 2025
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 611, 112691
Melatonin administration protects the right ventricle from adrenergic stress via anti-inflammatory and anti-apoptotic mechanisms
- 29 October 2025
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 611, 112691
Melatonin administration protects the right ventricle from adrenergic stress via anti-inflammatory and anti-apoptotic mechanisms
- 30 August 2025
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 477 (10) , 1273-1285
Evaluation of the use of the myocardial performance index as a parameter of cardiac function in two experimental models of heart disease: myocardial infarction and pulmonary hypertension
Myocardial performance index (MPI) has been used in the estimation of ventricular function in a non-invasive way through echocardiography. This index has presented relevant results in clinical and experimental studies. However, there are no studies evaluating whether this index correlates with other cardiac parameters in experimental models of heart disease, such as monocrotaline-induced pulmonary artery hypertension (PAH) and acute myocardial infarction (AMI). In view of that, the present study evaluated rats submitted to PAH and perform a broad analysis of echocardiographic, hemodynamic and morphometric parameters of the right ventricle (RV) and pulmonary artery (PA). Besides that, the present study also evaluated rats submitted to experimental AMI and performed a broad echocardiographic evaluation of left ventricle (LV). Subsequently, it was analyzed whether the parameters collected presented correlation with the MPI. In PAH model, monocrotaline was administrated and the animals were divided into the following groups: control and PAH. In AMI model, infarction was induced by coronary artery ligation and the groups were as follows: SHAM and AMI. In PAH model, MPI presented correlation with RV functional parameters, as well as with parameters that evaluate flow and resistance in the PA. In addition, this index also presented correlation with LV parameters in infarcted rats. To our knowledge, this is the first study that evaluates the correlation of MPI with parameters of the RV in rats with PAH induce by monocrotaline. Besides that, this is the first study that compares the use of this index in two different experimental models of cardiac diseases.
- 30 August 2025
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 477 (10) , 1273-1285
Evaluation of the use of the myocardial performance index as a parameter of cardiac function in two experimental models of heart disease: myocardial infarction and pulmonary hypertension
Myocardial performance index (MPI) has been used in the estimation of ventricular function in a non-invasive way through echocardiography. This index has presented relevant results in clinical and experimental studies. However, there are no studies evaluating whether this index correlates with other cardiac parameters in experimental models of heart disease, such as monocrotaline-induced pulmonary artery hypertension (PAH) and acute myocardial infarction (AMI). In view of that, the present study evaluated rats submitted to PAH and perform a broad analysis of echocardiographic, hemodynamic and morphometric parameters of the right ventricle (RV) and pulmonary artery (PA). Besides that, the present study also evaluated rats submitted to experimental AMI and performed a broad echocardiographic evaluation of left ventricle (LV). Subsequently, it was analyzed whether the parameters collected presented correlation with the MPI. In PAH model, monocrotaline was administrated and the animals were divided into the following groups: control and PAH. In AMI model, infarction was induced by coronary artery ligation and the groups were as follows: SHAM and AMI. In PAH model, MPI presented correlation with RV functional parameters, as well as with parameters that evaluate flow and resistance in the PA. In addition, this index also presented correlation with LV parameters in infarcted rats. To our knowledge, this is the first study that evaluates the correlation of MPI with parameters of the RV in rats with PAH induce by monocrotaline. Besides that, this is the first study that compares the use of this index in two different experimental models of cardiac diseases.
- 22 April 2025
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 57 (05) , 346-354
Testosterone Deprivation Impairs Cardiac Systolic Function in Orchiectomized Wistar Rats
Several studies have linked low levels of testosterone with increased symptoms of cardiac disease and cardiovascular mortality; however, the effects of testosterone deficiency on cardiac systolic function and morphology are still not completely elucidated. The present study aims to evaluate the influence of testosterone deprivation on cardiac systolic function and morphology. Male Wistar rats were divided into two groups: Sham operation group (Sham): animals underwent sham operation and Orchiectomized group (Orchiec): animals underwent bilateral orchiectomy. The experimental protocol lasted 60 days after the surgery. All animals were weighted and blood samples collected to serum testosterone analysis, determined by chemiluminescence, on first (before orchiectomy) and on 60th days. One day before euthanasia (on the 59th day) echocardiographic parameters were assessed to evaluate left ventricle (LV) systolic function and morphology. Statistical significant difference was set at≤0.05. Orchiec rats presented reduced LV fractional shortening (p=0.032), increased myocardial performance index (MPI) (p=0.043), prolonged mitral valve closure time (p=0.013) and decreased heart rate (p=0.049) when compared to Sham. No statistically significant difference was found in the ejection fraction (p=0.666) between groups. Besides that, heart weight was lower in Orchiec group (p=0.035) when compared to Sham group. Testosterone deprivation reduced cardiac systolic function, changing contraction and relaxation parameters. Testosterone deficiency also changed heart rate and heart weight. The present study demonstrated for the first time that castrated levels of testosterone could alter parameters such as mitral valve closing time and MPI.
- 22 April 2025
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 57 (05) , 346-354
Testosterone Deprivation Impairs Cardiac Systolic Function in Orchiectomized Wistar Rats
Several studies have linked low levels of testosterone with increased symptoms of cardiac disease and cardiovascular mortality; however, the effects of testosterone deficiency on cardiac systolic function and morphology are still not completely elucidated. The present study aims to evaluate the influence of testosterone deprivation on cardiac systolic function and morphology. Male Wistar rats were divided into two groups: Sham operation group (Sham): animals underwent sham operation and Orchiectomized group (Orchiec): animals underwent bilateral orchiectomy. The experimental protocol lasted 60 days after the surgery. All animals were weighted and blood samples collected to serum testosterone analysis, determined by chemiluminescence, on first (before orchiectomy) and on 60th days. One day before euthanasia (on the 59th day) echocardiographic parameters were assessed to evaluate left ventricle (LV) systolic function and morphology. Statistical significant difference was set at≤0.05. Orchiec rats presented reduced LV fractional shortening (p=0.032), increased myocardial performance index (MPI) (p=0.043), prolonged mitral valve closure time (p=0.013) and decreased heart rate (p=0.049) when compared to Sham. No statistically significant difference was found in the ejection fraction (p=0.666) between groups. Besides that, heart weight was lower in Orchiec group (p=0.035) when compared to Sham group. Testosterone deprivation reduced cardiac systolic function, changing contraction and relaxation parameters. Testosterone deficiency also changed heart rate and heart weight. The present study demonstrated for the first time that castrated levels of testosterone could alter parameters such as mitral valve closing time and MPI.
- Open Access
- 26 February 2025
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 47 (1) , 103744
Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia
- 26 February 2025
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 47 (1) , 103744
Open AccessImpact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia
- 2 January 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 131 (3) , 455-466
Melatonin improves adverse vascular remodelling and redox homeostasis in monocrotaline-induced pulmonary arterial hypertension
This study explored the effects of melatonin on cardiac and vascular function, and redox homeostasis in model PAH. Male Wistar rats were divided into: control (CTR), monocrotaline [MCT (60 mg/kg, single dose i.p)], monocrotaline + sildenafil [MCT + SIL (50 mg/kg/day)], and monocrotaline + melatonin [MCT + MEL (10 mg/kg/day)]. This protocol lasted 21 days. Echocardiographic, morphometric, histological, vascular reactivity, and oxidative/nitrosative stress analyses were performed. The reduced diastolic function and AT/ET ratio in the MCT group were partially attenuated by melatonin and sildenafil treatment (p < 0.05). Increased RV hypertrophy and pulmonary congestion were reduced by both treatments (p < 0.05). MCT-induced pulmonary arteriolar muscle layer hypertrophy was also reduced by both treatments (p < 0.05). MCT and MCT + SIL present diminished vasorelaxation as compared to control (p < 0.05). Augmented oxidative/nitrosative stress and reduced glutathione-s-transferase activity in MCT were mitigated by both treatments (p < 0.05). Then, melatonin was as effective as sildenafil against PAH-induced oxidative stress and pathological vascular remodelling.
- 2 January 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 131 (3) , 455-466
Melatonin improves adverse vascular remodelling and redox homeostasis in monocrotaline-induced pulmonary arterial hypertension
This study explored the effects of melatonin on cardiac and vascular function, and redox homeostasis in model PAH. Male Wistar rats were divided into: control (CTR), monocrotaline [MCT (60 mg/kg, single dose i.p)], monocrotaline + sildenafil [MCT + SIL (50 mg/kg/day)], and monocrotaline + melatonin [MCT + MEL (10 mg/kg/day)]. This protocol lasted 21 days. Echocardiographic, morphometric, histological, vascular reactivity, and oxidative/nitrosative stress analyses were performed. The reduced diastolic function and AT/ET ratio in the MCT group were partially attenuated by melatonin and sildenafil treatment (p < 0.05). Increased RV hypertrophy and pulmonary congestion were reduced by both treatments (p < 0.05). MCT-induced pulmonary arteriolar muscle layer hypertrophy was also reduced by both treatments (p < 0.05). MCT and MCT + SIL present diminished vasorelaxation as compared to control (p < 0.05). Augmented oxidative/nitrosative stress and reduced glutathione-s-transferase activity in MCT were mitigated by both treatments (p < 0.05). Then, melatonin was as effective as sildenafil against PAH-induced oxidative stress and pathological vascular remodelling.
- 22 December 2024
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 131 (3) , 445-454
Boldine reduces left ventricle oxidative stress in isoproterenol-induced adrenergic overload experimental model
Sustained adrenergic overload in the heart causes maladaptive cardiac remodelling, which involves oxidative stress. Boldine (BOL) has antioxidant activity and represents a novel therapeutic approach. This study explored the cardioprotective role of BOL in adverse left ventricular remodelling induced by isoproterenol. The rats were divided into four groups: control; BOL (25 mg/kg daily); isoproterenol (ISO) (5 mg/kg daily), and ISO + BOL. Morphometric, echocardiographic, and oxidative stress parameters were evaluated. BOL attenuated both cardiac hypertrophy and increased diastolic volume caused by adrenergic overstimulation (P < 0.05). BOL treatment reduced lipid peroxidation induced by ISO (ISO vs. ISO + BOL; P < 0.05), and this effect was associated with increased superoxide dismutase (SOD) (ISO vs. ISO + BOL; P < 0.05) and glutathione-S-transferase levels (GST) (ISO vs. ISO + BOL; P < 0.05). This data suggest that BOL may improve cardiac oxidative stress and attenuate some parameters of adverse cardiac remodelling.
- 22 December 2024
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 131 (3) , 445-454
Boldine reduces left ventricle oxidative stress in isoproterenol-induced adrenergic overload experimental model
Sustained adrenergic overload in the heart causes maladaptive cardiac remodelling, which involves oxidative stress. Boldine (BOL) has antioxidant activity and represents a novel therapeutic approach. This study explored the cardioprotective role of BOL in adverse left ventricular remodelling induced by isoproterenol. The rats were divided into four groups: control; BOL (25 mg/kg daily); isoproterenol (ISO) (5 mg/kg daily), and ISO + BOL. Morphometric, echocardiographic, and oxidative stress parameters were evaluated. BOL attenuated both cardiac hypertrophy and increased diastolic volume caused by adrenergic overstimulation (P < 0.05). BOL treatment reduced lipid peroxidation induced by ISO (ISO vs. ISO + BOL; P < 0.05), and this effect was associated with increased superoxide dismutase (SOD) (ISO vs. ISO + BOL; P < 0.05) and glutathione-S-transferase levels (GST) (ISO vs. ISO + BOL; P < 0.05). This data suggest that BOL may improve cardiac oxidative stress and attenuate some parameters of adverse cardiac remodelling.
- 1 July 2024
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 84 (1) , 101-109
Effects of Pterostilbene on Heart and Lung Oxidative Stress Parameters in 2 Experimental Models of Cardiovascular Disease: Myocardial Infarction and Pulmonary Arterial Hypertension
Myocardial infarction (MI) and pulmonary arterial hypertension (PAH) are 2 prevalent cardiovascular diseases. In both conditions, oxidative stress is associated with a worse prognosis. Pterostilbene (PTE), an antioxidant compound, has been studied as a possible therapy for cardiovascular diseases. This study aims to evaluate the effect of PTE on oxidative stress in the hearts of animals with MI and in the lungs of animals with PAH. Male Wistar rats were used in both models. In the MI model, the experimental groups were sham, MI, and MI + PTE. In the PAH model, the experimental groups were control, PAH, and PAH + PTE. Animals were exposed to MI through surgical ligation of the left coronary artery, or to PAH, by the administration of monocrotaline (60 mg/kg). Seven days after undergoing cardiac injury, the MI + PTE animals were treated with PTE (100 mg/kg day) for 8 days. After this, the heart was collected for molecular analysis. The PAH + PTE animals were treated with PTE (100 mg/kg day) for 14 days, beginning 7 days after PAH induction. After this, the lungs were collected for biochemical evaluation. We found that PTE administration attenuated the decrease in ejection fraction and improved left ventricle end-systolic volume in infarcted animals. In the PAH model, PTE improved pulmonary artery flow and decreased reactive oxygen species levels in the lung. PTE administration promoted protective effects in terms of oxidative stress in 2 experimental models of cardiac diseases: MI and PAH. PTE also improved cardiac function in infarcted rats and pulmonary artery flow in animals with PAH.
- 1 July 2024
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 84 (1) , 101-109
Effects of Pterostilbene on Heart and Lung Oxidative Stress Parameters in 2 Experimental Models of Cardiovascular Disease: Myocardial Infarction and Pulmonary Arterial Hypertension
Myocardial infarction (MI) and pulmonary arterial hypertension (PAH) are 2 prevalent cardiovascular diseases. In both conditions, oxidative stress is associated with a worse prognosis. Pterostilbene (PTE), an antioxidant compound, has been studied as a possible therapy for cardiovascular diseases. This study aims to evaluate the effect of PTE on oxidative stress in the hearts of animals with MI and in the lungs of animals with PAH. Male Wistar rats were used in both models. In the MI model, the experimental groups were sham, MI, and MI + PTE. In the PAH model, the experimental groups were control, PAH, and PAH + PTE. Animals were exposed to MI through surgical ligation of the left coronary artery, or to PAH, by the administration of monocrotaline (60 mg/kg). Seven days after undergoing cardiac injury, the MI + PTE animals were treated with PTE (100 mg/kg day) for 8 days. After this, the heart was collected for molecular analysis. The PAH + PTE animals were treated with PTE (100 mg/kg day) for 14 days, beginning 7 days after PAH induction. After this, the lungs were collected for biochemical evaluation. We found that PTE administration attenuated the decrease in ejection fraction and improved left ventricle end-systolic volume in infarcted animals. In the PAH model, PTE improved pulmonary artery flow and decreased reactive oxygen species levels in the lung. PTE administration promoted protective effects in terms of oxidative stress in 2 experimental models of cardiac diseases: MI and PAH. PTE also improved cardiac function in infarcted rats and pulmonary artery flow in animals with PAH.
- 24 May 2024
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 591, 112279
Melatonin improves nitric oxide bioavailability in isoproterenol induced myocardial injury
- 24 May 2024
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 591, 112279
Melatonin improves nitric oxide bioavailability in isoproterenol induced myocardial injury